Mean pancreatic insulin mRNA levels in T1DM mice treated with empagliflozin (3mg/kg) were significantly increased by 60% compared with the vehicle group (Fig 2A; vehicle 1.00±0.13 vs empagliflozin 1.60±0.18). This evidence concerns the gene INS and type 1 diabetes mellitus.